[no subject]

[owner-indices@healthnet.org]

<0402819922B44E4CA0860B3EB619862C083BE781@exstaffb.levels.unisa.edu.au>
From: Agnes Vitry <Agnes.Vitry@unisa.edu.au>
To: "'indices@healthnet.org'" <indices@healthnet.org>
Subject: INDICES> Perhexiline
Sender: owner-indices@usa.healthnet.org
Precedence: bulk
Reply-To: indices@usa.healthnet.org

INDICES> Perhexiline
--------------------

One of my Honours students is doing her research on evidence for use of
perhexiline (brand name Pexid). It seems that perhexiline is not marketed
anymore except in Australia and New Zealand. Please could you confirm that
Pexid has been discontinued in all European countries, in particular in
Germany, Italy and Belgium?

Thanks

Agnes Vitry
Lecturer
Quality Use of Medicines and Pharmacy Research Centre
School of Pharmaceutical, Molecular and Biomedical Sciences
University of South Australia
City East Campus, Adelaide SA 5000
Telephone: 61 8 83022392
Facsimile: 61 8 83022389
Email: agnes.vitry@unisa.edu.au

[please respond directly to Agnes at agnes.vitry@unisa.edu.au
thanks WB]
--
To send a message to Indices, write to: indices@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe indices OR unsubscribe indices
To contact a person, send a message to: indices-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/indices/